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Abstract
Background: This study was undertaken to test the hypothesis that the newly syn-
thesized curcuminoids B2BrBC and C66 supplementation will overcome hyperoxia-
induced tracheal hyperreactivity and impairment of relaxation of tracheal smooth 
muscle (TSM).
Materials and methods: Rat pups (P5) were exposed to hyperoxia (>95% O2) or 
normoxia for 7 days. At P12, tracheal cylinders were used to study in vitro contractile 
responses induced by methacholine (10−8–10−4M) or relaxation induced by electrical 
field stimulation (5–60 V) in the presence/absence of B2BrBC or C66, or to study the 
direct relaxant effects elicited by both analogs.
Results: Hyperoxia significantly increased contraction and decreased relaxation of 
TSM compared to normoxia controls. Presence of B2BrBC or C66 normalized both 
contractile and relaxant responses altered by hyperoxia. Both, curcuminoids directly 
induced dose-dependent relaxation of preconstricted TSM. Supplementation of hy-
peroxic animals with B2BrBC or C66, significantly increased catalase activity. Lung 
TNF-α was significantly increased in hyperoxia-exposed animals. Both curcumin 
analogs attenuated increases in TNF-α in hyperoxic animals.
Conclusion: We show that B2BrBC and C66 provide protection against adverse 
contractility and relaxant effect of hyperoxia on TSM, and whole lung inflamma-
tion. Both analogs induced direct relaxation of TSM. Through restoration of catalase 
activity in hyperoxia, we speculate that analogs are protective against hyperoxia-in-
duced tracheal hyperreactivity by augmenting H2O2 catabolism. Neonatal hyperoxia 
induces increased tracheal contractility, attenuates tracheal relaxation, diminishes 
lung antioxidant capacity, and increases lung inflammation, while monocarbonyl 
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1 |  INTRODUCTION
Chronic lung disease of prematurity, bronchopulmonary dys-
plasia (BPD), is a result of lung injury complications during 
the treatment of respiratory failure in premature infants, and 
is manifested with increased airway reactivity in childhood 
(Hack et al., 2005; Pelkonen, Hakulinen, & Turpeinen, 1997). 
In addition to the pre- and postnatal inflammatory processes, 
exposure of immature respiratory tracts to supplemental 
oxygen plays an important role in the development of BPD 
(Kinsella, Greenough, & Abman, 2006). Hence, BPD can 
be induced by hyperoxic exposure throughout the neonatal 
period of rodents and serves as a model for BPD-associated 
airway reactivity. Previously, it was shown by us and other 
authors that neonatal exposure to a high concentration of 
oxygen (>95%) is associated with increased contractile re-
sponses and decreased relaxant responses of airway smooth 
muscle (ASM), measured under in vitro and in vivo condi-
tions on extra- and intrapulmonary airways (Belik, Jankov, 
Pan, & Tanswell, 2003; Hershenson et  al.,  1994; Iben, 
Dreshaj, Farver, Haxhiu, & Martin, 2000; Mhanna et al., 
2004; Sopi et al., 2007, 2008; Vadivel et al., 2010).
Hyperoxic exposure induces reactive oxygen species 
(ROS) generation in the lungs (Berkelhamer et  al.,  2013), 
which is known to be associated with BPD pathophysiology 
(Nardiello, Mizikova, & Morty, 2017). With respect to the 
relationship between airway function and persistent oxygen 
susceptibility, a potential therapeutic approach would be to re-
duce ROS directly by improving the cellular antioxidant sys-
tem, in efforts to normalize future airway function. Curcumin 
(CUR), is a naturally bioactive compound which possesses 
antioxidant properties (Comhair, Bhathena, Dweik, Kavuru, 
& Erzurum, 2000). Several studies have reported beneficial 
biological properties for CUR including antiinflammatory 
and antioxidant (Chainani-Wu, 2003), antimicrobial (Han & 
Yang,  2005), and hepatoprotective effects (Park, Jeon, Ko, 
Kim, & Sohn, 2000). CUR has been demonstrated to in-
hibit nitric oxide (NO) production by inducible NO synthase 
(iNOS) and ROS production in macrophages (Rao,  1997), 
and to enhance the activity of many antioxidant enzymes 
such as catalase (CAT), superoxide dismutase (SOD), gluta-
thione peroxidase (GPx) (Reddy & Lokesh, 1994), and heme 
oxygenase-1 (HO-1) (Jeong et al., 2006). Despite these char-
acteristics, it has limited clinical application due to its low 
bioavailability combined with rapid metabolism and poor 
chemical stability (Ren & Sowers,  2014). With biochem-
ical engineering, Ren and Sowers,  (2014), have found that 
reducing dicarbonyl with monocarbonyl groups improves 
both CUR bioavailability and stability. In this way, mono-
carbonyl CUR analogs have undergone extensive studies due 
to their useful biological properties (Zhao, Liu, & Liang, 
2013). Several studies focused on the use of (2E, 6E)-2,6-bis 
[(2-trifluoromethyl) benzylidene] cyclohexanone (so-called 
C66), showing that C66 has antioxidant activity (Pan et al., 
2012, 2014). Qian et  al.  (2015), introduced replacement of 
one trifluoromethyl group with bromine (Justino, Rodrigues, 
Florencio, & Mira, 2009), to further increase antioxidant 
activity. Moreover, the same authors in their studies in a 
mouse model of cardiac injury, have shown that (2E, 6E)-
2-(2-bromobenzylidene)-6-[(2-trifluoromethyl) benzylidene] 
cyclohexanone (called Y20) has increased antioxidant prop-
erties in comparison to C66. Based on this, we rationalized 
that replacing the additional trifluoromethyl group of Y20 
with bromine would result in significantly greater antioxi-
dant properties without altering the analog's antiinflamma-
tory properties (Hadzi-Petrushev et al., 2018).
When dealing with bronchial dysfunction and related 
complications, the ideal compounds would have both an-
tiinflammatory and antioxidant effects. Recently, CUR’s 
have been shown to exert antiinflammatory effects by 
inhibiting the release of proinflammatory cytokines 
(Camacho-Barquero et al., 2007; Fu et al., 2014; Sugimoto 
et al., 2002). Recent studies further demonstrate that CUR 
attenuates the development of asthma via inhibition of 
nuclear factor-κB (NF-κB) (Oh et  al.,  2011). In addition, 
CUR could induce vascular relaxation in porcine coronary 
artery (Xu, Long, Dai, & Liu, 2007) and goat ruminal ar-
tery (Dash & Parija,  2013). Although methanolic extract 
from Curcuma longa L could relax the rat mesenteric artery 
(Adaramoye et  al.,  2009), the relaxant effect of CUR on 
the airway and its mechanism of action are lacking. Also, 
there have not yet been studies showing the effect of the 
newly synthesized candidates (2E, 6E)-2,6-bis (2-bromo-
benzylidene) cyclohexanone (B2BrBC) and C66 on hyper-
oxia-induced impairment of ASM relaxation. Therefore, 
this study was undertaken to test the hypothesis that CUR 
analogs, B2BrBC and C66 act on the level of TSM in a rat 
pup model of BPD, and that B2BrBC/C66 supplementation 
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CUR analogs were protective of these adverse effects of hyperoxia. Analogs may be 
promising new therapies for neonatal hyperoxic airway and lung disease.
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will reverse hyperoxia-induced increased contraction and 
impaired relaxation of TSM. Further we sought to deter-
mine the antioxidative and antiinflammatory effect of these 
compounds in our experimental model of BPD.
2 |  MATERIALS AND METHODS
2.1 | Animals and experimental design
Experiments were performed on Wistar rat pups. On the 5th 
day of life (P5) pups from two different litters were randomly 
mixed and assigned to either hyperoxia (n = 20; [12 males 
and 8 females]) or normoxia groups (n = 20; [11 males and 
9 females]) and exposed for 7 days to hyperoxia >95% O2 or 
kept in room air (normoxia). Animals (mothers) were pro-
vided with water and food ad libitum, while a 12-hr on/12-
hr off light cycle was maintained. Hyperoxic groups were 
housed with their mothers in a Plexiglas chamber (38 L) and 
exposed to a continuous flow of O2 (2  L/min) for 7  days, 
while normoxic groups were kept in a commercial rat cage in 
normal environmental air with their mothers. Mothers were 
rotated every 24 hr between normoxic and hyperoxic groups 
to control for hyperoxic exposure. Oxygen concentration 
within a chamber was monitored continuously via an oxygen 
analyzer (MiniOX-1, Ohio Medical Corporation). Pups from 
both sexes were included in these experiments and no differ-
ences were observed between sexes in this study. All experi-
mental procedures were conducted in accordance with the 
Guiding Principles for Care and Use of Laboratory Animals 
and were approved by the Ethics Committees’ of our institu-
tions at Ss. Cyril and Methodius University and University 
of Prishtina.
2.2 | In vitro measurement of 
contraction and relaxation of TSM
After the exposure time on day 12 of postnatal life (P12), ani-
mals were euthanized by asphyxiation in CO2. The trachea 
was removed and prepared free of serosal connective tis-
sue in an ice-cold oxygenated Krebs–Henseleit (KH) buffer 
(concentration in mM: 118.2 NaCl, 25 NaHCO3, 4.6 KCl, 
1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, and 10% D-glucose, 
pH = 7.4; all obtained from Sigma-Aldrich). Two cylindrical 
airway segments of 3-mm length were isolated from the mid-
portions of the tracheas for each animal, and transferred into 
a tissue-organ bath containing KH buffer (10 ml) at 37°C, as 
previously described (Sopi et al., 2012).
Tracheal preparations placed in tissue-organ baths were 
suspended between a stainless steel hook at the bottom of the 
organ-tissue bath and a force displacement transducer above 
the bath. TSM tension was measured by the four channel 
organ bath system integrated with data Acquisition & Control 
Software (DMT - 750TOBS, Danish Myo Technology) in-
terfaced with computer software (LabChart). The tension of 
TSM tissue was expressed in grams (g). An initial load rang-
ing from 0.2 to 0.3 g was applied, and then tissues were al-
lowed to equilibrate for 45 min in the organ baths containing 
KH buffer (10 ml) at 37°C. Preparations were rinsed every 
15 min with KH solution during the equilibration time and 
the solution was continuously aerosolized with a gas mixture 
(95% O2 and 5% CO2).
2.3 | The effect of B2BrBC and C66 on 
contractile responses of TSM to methacholine
To study the effect of CUR analogs, B2BrBC and C66 on 
TSM contraction, tracheal preparations from both hyperoxic 
and normoxic animals were established in the organ baths, 
then a dose–response curve was constructed using metha-
choline (MCh, 10−8–10−4  M) (Sigma-Aldrich) as an exog-
enous constrictive agonist in absence or presence of B2BrBC 
(100 μg/ml) or C66 (100 μg/ml). For in vitro supplementation 
the newly synthesized CUR analogs were dissolved in dis-
tilled water. Tissues were incubated in these compounds for 
30 min prior to MCh application. The time between doses of 
MCh were monitored until the TSM reached plateau contrac-
tility. At the end of each cumulative MCh dose–response, the 
preparations were washed-out three times every five minutes 
with warmed KH solution and the TSM were relaxed to base-
line for an additional 45 min.
2.4 | The role of B2BrBC and C66 on 
relaxant responses of TSM
In order to show the effect of hyperoxia on relaxant responses 
of TSM, preparations obtained from both hyperoxia- and 
normoxia-exposed animals were placed in organ baths as de-
scribed above. After equilibration back to baseline following 
the methacholine dose–response as described above, a cumu-
lative dose–response curve was then built to find a concentra-
tion of the long-acting muscarinic agonist bethanechol that 
elicited a 75% of maximal response in TSM. A concentration 
of 50 μM bethanechol was found to be the optimal dose to 
elicit 75% of maximal response. Tissues were preconstricted 
using a single dose of bethanechol (50 μM; Sigma-Aldrich), 
then incremental electrical field stimulation (EFS) was ap-
plied to the preconstricted TSM through platinum electrodes 
(5–60 V alternating current [AC] at 50 Hz) for 10 s at 2-min 
intervals to induce relaxation, as we have previously de-
scribed (Sopi et al., 2007, 2008). The relaxation of the TSM 
was expressed as percentage (%) of preconstricted tension for 
each preparation.
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To determine whether B2BrBC and/or C66 can restore the 
relaxant responses impaired by hyperoxia, the preparations 
were incubated in B2BrBC (100 μg/ml) or C66 (100 μg/ml) 
for 30 min, then EFS was applied.
In another set of experiments, to study the direct relaxant 
effect of CUR analogs on ASM, cumulative doses of B2BrBC 
(20, 50, 200 μg/ml) or C66 (20, 50, 200 μg/ml) were applied 
to preconstricted TSM preparations with bethanechol (50 μM).
2.5 | The effect of B2BrBC and C66 on 
antioxidant enzymes
In order to examine the effect of B2BrBC and C66 on the activ-
ity of endogenous antioxidant enzymes (CAT, SOD and GPx), 
under hyperoxia and normoxia conditions pups were treated 
from P5 to P12 with 20 mg/kg b.w/day of i.p B2BrBC and C66, 
respectively. B2BrBC and C66 were dissolved in oil. Control 
animals of hyperoxia and normoxia groups received vehicle 
only. CAT activity was determined by measuring the degrada-
tion of hydrogen peroxide (H2O2), using the method described 
by (Claiborne, 1985). SOD activity was determined according 
to the method described by Marklund and Marklund, (1974), 
based on the ability of SOD to inhibit the auto-oxidation of py-
rogallol. The activity of GPx was determined according to the 
method described by (Lawrence & Burk, 1976). The detailed 
procedure for sample preparation is described in our previous 
studies (Hadzi-Petrushev, Jankulovski, Hristov, & Mladenov, 
2011; Hadzi-Petrushev et al., 2012; Mladenov, Gokik, Hadzi-
Petrushev, Gjorgoski, & Jankulovski, 2015). The protein con-
tent of the lung samples was determined using the method 
described by (Lowry, Rosebrough, Farr, & Randall, 1951).
2.6 | Immuno-assays for 
proinflammatory cytokines
Tumor necrosis factor alpha (TNF-α) and interleukin 1-beta 
(IL-1β), in the lung tissue homogenates were analyzed using 
the newly developed ELISA for quantitative analysis of 
TNF-α and IL-1β levels from Bender Med-Systems. The 
limits of detection of the assays were about 2.3  pg/ml for 
TNF-α and 1.0 pg/ml for IL-1β. Inter- and intra-assay CVs 
were 8.2% and 9.6% for TNF-α and 6.5% and 3.2% for IL-1β. 
The detailed procedure for sample preparation is described in 
our previous studies (Hadzi-Petrushev, Stojkovski, Mitrov, 
& Mladenov, 2014; Mitrov et al., 2014).
2.7 | Statistical analysis
Data are expressed as mean  ±  SEM. Statistical signifi-
cance was determined by two-way ANOVA with repeated 
measurements to determine the differences between MCh-; 
EFS- induced contraction or relaxation responses of hyper-
oxia versus normoxia; hyperoxia + B2BrBC and/or hyper-
oxia + C66 versus. hyperoxia control; normoxia + B2BrBC 
and/or normoxia  +  C66 versus. normoxia control groups. 
To compare Emax or EC50 values between two groups a t test 
was used after checking for normal distribution. To analyze 
the differences between individual concentrations of par-
ticular drugs or individual voltages, post hoc comparison 
via Tukey–Kramer multiple comparison test was used. The 
statistical significance of CAT, SOD and GPx activity and 
TNF-α and IL-1β levels was determined by Tukey's post hoc 
comparisons to identify pairwise differences for all signifi-
cant ANOVA findings. p  <  .05 was considered as statisti-
cally significant.
2.8 | General 
characteristics of the chemicals
General characteristics of the chemicals and synthesis of 
2,6-Bis(2-X-benzylidene) cyclohexanone derivatives are de-
scribed in our previous study (Hadzi-Petrushev et al., 2018).
3 |  RESULTS
3.1 | Effect of B2BrBC and C66 on 
hyperoxia-enhanced TSM contractile responses
Hyperoxia significantly increased contractile responses of 
TSM to MCh compared with contractile responses generated 
in preparations obtained from normoxic animals (p < .001). 
As shown in Figure 1a, the contractile responses of TSM from 
pups exposed to hyperoxia (n = 8) were significantly greater 
than those from TSM of normoxic pups (n = 8) at concentra-
tions 10−5.5–10−4 M of MCh. There was a significant increase 
in Emax values of TSM contractile responses in the hyper-
oxic group compared to the normoxic group (2.94 ± 0.14 g 
and 2.25  ±  0.07  g, respectively), but the difference in the 
EC50 values [MCh (−log M)] between hyperoxia and nor-
moxia groups was not statistically significant (6.05 ± 0.09 vs. 
5.99 ± 0.24, respectively; Table 1).
In vitro supplementation of tissues with B2BrBC or C66 re-
versed the hyperoxia-induced airway hyperreactivity to MCh. 
In the presence of B2BrBC or C66, TSM contractile responses 
(Figure 1a; n = 8, in both sets of experiments) were significantly 
decreased at concentrations 10−5–10−4 M or 10−4.5–10−4 M of 
MCh, respectively, as compared to hyperoxia control responses 
from the same animals in absence of these compounds (overall, 
p < .01 and p < .05, respectively). Emax values of TSM contrac-
tile responses in hyperoxia + B2BrBC and hyperoxia + C66 
were 2.52 ± 0.14 g and 2.59 ± 0.13 g, respectively (Table 1). 
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Although, CUR analogs significantly decreased Emax values of 
TSM contractile responses in hyperoxia-exposed pups, there 
was no significant difference in EC50 values [MCh (−log M)] 
between hyperoxia control; hyperoxia + B2BrBC and hyper-
oxia + C66 (6.05 ± 0.09; 6.18 ± 0.18 and 5.97 ± 0.09, respec-
tively; Table 1).
CUR analogs had no significant effect on TSM contractile 
responses in the normoxic group (Figure 1b).
3.2 | Effect of B2BrBC and C66 on 
hyperoxia impaired relaxation of TSM
In hyperoxic animals, relaxation of TSM induced by EFS 
overall was significantly reduced, as compared to room 
air exposed animals (p  <  .001). As shown in Figure  2a, 
the relaxant responses of TSM from pups exposed to hy-
peroxia (n = 6) were significantly attenuated compared to 
TSM of room air pups (n = 6), from 20 to 60 V. The data 
of relaxant responses in hyperoxic and normoxic group 
ranged from 0.81  ±  0.20% at 5  V to 37.40  ±  1.88% at 
60 V, and from 2.39 ± 0.26% at 5 V to 84.37 ± 2.61% at 
60 V, respectively.
B2BrBC reversed the effects of hyperoxia attenuation of 
relaxant responses in TSM, but C66 did not show any signif-
icant effect on relaxant responses under these conditions. As 
shown in Figure 2a, the relaxant responses of TSM to EFS 
in the hyperoxic group were significantly increased (over-
all, p  <  .001) when the preparations were preincubated in 
B2BrBC as compared to the relaxant responses in absence 
F I G U R E  1  Effect of B2BrBC and C66 on hyperoxia-induced airway hyperreactivity in rat pups. (a) In hyperoxic group of animals 
(n = 8) contractile responses were greater than in normoxic group (n = 8) (p < .001). In the presence of B2BrBC (100 μg/ml) or C66 (100 μg/
ml) contractile responses of hyperoxic TSM were lower than those recorded in absence of these compounds. (b) In the normoxic group neither 
B2BrBC nor C66 had any effect on contractile responses of TSM. *Hyperoxia versus Normoxia; #Hyperoxia + B2BrBC versus Hyperoxia control; 
§Hyperoxia + C66 versus Hyperoxia control. **p < .01; ***p < .001; ##p < .01; §p < .05. Data represent mean ± SEM of eight experiments for 
each condition
T A B L E  1  Effect of B2BrBC or C66 on ASM hyperreactivity induced by hyperoxia
Group pEC50 (−log M) Emax (g) p-value (EC50) p-value (Emax)
Hyperoxia 6.05 ± 0.09 2.94 ± 0.18 .411 .0003 versus Normoxia
Hyperoxia + B2BrBc 6.18 ± 0.18 2.5 ± 0.14 .264 .025 versus Hyperoxia
Hyperoxia + C66 5.97 ± 0.09 2.5 ± 0.13 .297 .046 versus Hyperoxia
Normoxia 5.99 ± 0.24 2.25 ± 0.07 .267 .562 versus 
Hyperoxia + B2Br
Normoxia + B2BrBc 6.05 ± 0.06 2.1 ± 0.08 .410 .298 versus Normoxia
Normoxia + C66 6.07 ± 0.12 2.22 ± 0.08 .380 .385 versus Normoxia
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F I G U R E  2  Effect of B2BrBC and C66 on hyperoxia impaired EFS-induced relaxation of the TSM of rat pups. (a) In hyperoxia-exposed 
group of animals (n = 6) EFS-induced relaxation of TSM was reduced as compared to those obtained from normoxia-exposed group (n = 6). In 
the presence of B2BrBC (100 μg/ml) relaxant responses of hyperoxic TSM were restored and significantly higher than those recorded in absence 
of this compound (p < .001), while the presence of C66 (100 μg/ml) did not have any significant effect on EFS-induced relaxant responses 
of TSM. (b) B2BrBC or C66 did not have any effect on EFS-induced relaxation of TSM in normoxic group. *Hyp eroxia versus Normoxia; 
#Hyperoxia + B2BrBC versus Hyperoxia control; §Normoxia control versus Hyperoxia + B2BrBC; †Normoxia control versus Hyperoxia + C66. 
*p < .05; ***p < .001; ###p < .001; §§§p < .001; †††p < .001. Data represent mean ± SEM of six experiments for each condition
F I G U R E  3  Relaxant responses of airway smooth muscle towards different concentrations of B2BrBC-(A) and C66-(B). (a,b) B2BrBC and 
C66, both induced direct concentration-dependent relaxation of preconstricted TSM, and the difference was significant between different doses 
within a same group and across different groups (Hyperoxia & Normoxia – 200 μg/ml versus Hyperoxia & Normoxia – 50 or 20 μg/ml, p < .001; 
Hyperoxia & Normoxia – 50 μg/ml versus Hyperoxia & Normoxia – 20 μg/ml, p < .01). Data represent mean ± SEM of eight experiments
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of this compound, particularly at higher voltages (30–60 V). 
The relaxation data under condition of supplementation with 
B2BrBC ranged from 1.66 ± 0.51% at 5 V to 63.98 ± 3.38% 
at 60 V. Relaxant responses of TSM to EFS in the hyperoxic 
group did not significantly differ in the presence of C66. The 
data ranged from 1.15 ± 0.27% at 5 V to 41.27 ± 2.81% at 
60 V. Both, B2BrBC or C66 did not show any significant ef-
fect on EFS-induced TSM relaxation in the normoxic group 
(Figure 2b).
3.3 | B2BrBC and C66 induced 
concentration-dependent relaxation of TSM
In order to define the direct relaxant effect of CUR ana-
logs on TSM, preconstricted TSM were challenged with 
different concentrations of B2BrBC or C66 (20, 50 and 
200 μg/ml). B2BrBC induced a concentration-dependent 
relaxation of TSM in both, hyperoxic (n  =  8) and nor-
moxic (n = 6) groups (Figure 3a). There was significant 
relaxation with increasing concentrations of B2BrBC 
within each group (p  <  .001), but not a significant dif-
ference between normoxic and hyperoxic groups at the 
same dose.
Interestingly, the presence of C66 did not restore EFS-
induced relaxation of TSM obtained from hyperoxic rat pups 
(Figure 2a), but in preconstricted TSM C66 triggered concen-
tration-dependent relaxation in both hyperoxic (n = 8) and 
normoxic (n = 6) groups (Figure 3a,b). There was a signif-
icant difference in relaxant effects observed with increasing 
concentrations of C66 within each group (p < .001), but not 
a significant difference between normoxic and hyperoxic 
groups at the same dose.
3.4 | Effect of B2BrBC and C66 on 
antioxidant activity
In comparison to the normoxic group, among the studied 
enzymes only CAT had significantly decreased catalytic 
activity in the hyperoxia-exposed group (n  =  8; p  <  .01), 
(Figure 4a). In terms of treatment, both CUR analogs possess 
high antioxidant capacity, expressed through preservation of 
catalytic activity of CAT during hyperoxic exposure (n = 8; 
p < .01). The treatment with CUR analogs did not show a 
significant change in the activity of CAT in normoxic ani-
mals. There was a tendency of increased lung SOD and GPx 
activity in hyperoxia-exposed pups (Figure 4b,c; p =  .059 
and p =  .053, respectively). Interestingly, in the normoxic 
controls treated with C66, SOD was significantly increased 
(n = 8; p < .01) and GPx was significantly decreased (n = 8; 
p < .01), while B2BrBC did not show an effect in normoxic 
controls.
3.5 | Effect of B2BrBC and C66 on 
proinflammatory cytokines
In relation to proinflammatory cytokines (TNF-α and IL-
1β), this study showed significantly increased expression 
F I G U R E  4  Effect of B2BrBC and C66 on CAT-(A), SOD-(B) 
and GPx-(C) activity. (a) Hyperoxia induced significant decrease in 
catalytic activity of CAT (p < .01). B2BrBC and C66 significantly 
preserved catalytic activity of CAT during hyperoxic exposure (n = 8; 
p < .01). (b,c) SOD and GPx showed nonsignificant increase in their 
activity under hyperoxic conditions (n = 8; p = .059 and p = .053, 
respectively). B2BrBC and C66 did not cause any change in the 
activity of CAT and SOD in normoxic pups. GPx was significantly 
decreased in the normoxic pups treated with C66 (n = 8; p < .01), 
while B2BrBC did not show any effect (n = 8; p > .05). *p < .05; 
**p < .01; n, number of pups; N, normoxic; H, hyperoxic; NC, 
normoxic treated with C66; HC, hyperoxic treated with C66; NB, 
normoxic treated with B2BrBC; HB, hyperoxic treated with B2BrBC
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of TNF-α in conditions of hyperoxia compared to normoxia 
(n = 8; p < .05). Treatment with both CUR analogs resulted 
in decreased expression of TNF-α in both, normoxia and hy-
peroxia (n = 8; p < .01; p < .01, respectively) (Figure 5a). 
IL-1β did not significantly differ in hyperoxia-exposed pups, 
but C66-treated normoxic pups had significantly decreased 
expression compared to normoxic controls (n = 8; p < .01) 
(Figure 5b).
4 |  DISCUSSION
Our previous studies in neonatal rats have shown that long-
term hyperoxic exposure disrupts the tracheal relaxation 
mechanisms (Ali et al., 2011; Sopi et al., 2007) and increases 
contraction of intrapulmonary airways in neonatal rats (Sopi 
et al., 2008) In this study, we have shown that exposure to hy-
peroxia causes a decrease in EFS-induced relaxation of TSM. 
We addressed the question whether redox modulation in the 
hyperoxic rat pup's lungs can be attenuated with postexposure 
CUR treatment (Rao, 1997). As expected, TSM preparations 
from hyperoxia-exposed rat pups, showed higher reactivity 
toward moderate and higher doses of methacholine, com-
pared to those from normoxic rat pups. This finding is based 
on several mechanisms, which include an imbalance of in-
creased contractile mediators accompanied with decreased 
relaxant mediators during hyperoxia (Belik et al., 2003).
Supplementation of tracheal preparations with CUR an-
alogs, B2BrBC or C66, significantly reduced contractile 
responses to MCh in hyperoxic animals. Pretreatment with 
CUR analogs did not cause any change in the EC50 but sig-
nificantly decreased the Emax contractile responses in TSM 
derived from hyperoxic animals; while no effect was observed 
in normoxic control animals. A lack of differences in EC50 
values of hyperoxia-exposed TSM preparations pretreated 
with B2BrBC or C66 compared to untreated, suggests sta-
bilized constrictive mediators’ release from the TSM. We 
speculate its physiological role is based on the induction of 
mechanisms participating in the processes concealed by mol-
ecules generated during oxidative processes such as H2O2.
Besides, the preventive effect on hyperoxic airway hyper-
reactivity, B2BrBC restored the impaired relaxant responses 
induced by EFS. In addition to the restoration of impaired 
relaxant responses, both, CUR analogs induced direct relax-
ation of TSM in a dose-dependent manner in preconstricted 
TSM. Our findings are in consent with published results 
showing the relaxant effect of curcumin on the smooth mus-
cle of different organs. Curcumin and its derivatives relax the 
rat aorta through a NO-independent pathway (Sasaki et al., 
2003). A direct relaxant effect of curcumin was shown in pre-
constricted guinea pigs’ gallbladder smooth muscle, through 
multiple signaling pathways, including protein kinase C, 
Ca2+ influx and K+ channels (Kline & Karpinski,  2015). 
Closer scrutiny of relaxation data (Figure  3a,b) show that 
CUR analogs induce relaxation of TSM in a dose-dependent 
manner. We are of the opinion that both B2BrBC and C66 
modulate the level of released H2O2 from the hyperoxic air-
ways in amounts that are below the transitory concentration 
necessary to induce contraction of smooth muscle (Shi et al., 
2007).
Hyperoxia causes the intrinsic imbalance between pro- 
and antioxidant mechanisms leading to oxidative stress and 
production of specific oxidative molecules on the level of 
the airways, such as H2O2 (Audi et  al.,  2018; Gil-Ortega 
et al., 2014). Hyperoxia decreased CAT activity, an enzyme 
that scavenges H2O2. H2O2 interacts with other molecules 
and triggers signaling pathways that lead to contraction 
of smooth muscle (Erdei et al., 2007). Our assumption is 
that released H2O2 in the TSM promotes constriction of 
TSM as a result of diminished CAT activity in the lungs 
F I G U R E  5  Effect of B2BrBC and C66 on TNF-α-(A) and IL-1β-(B). (a) Hyperoxia caused a highly significant increase on TNF-α (p < .01). 
B2BrBC and C66 caused significant prevention of hyperoxia-induced TNF-α increase (n = 8; p < .05), while in normoxic pups only C66 caused 
significant decrease in TNF-α (n = 8; p < .05). (b) In relation to IL-1β, significant changes were found only in C66-treated normoxic pups (n = 8; 
p < .05). *p < .05; **p < .01; n, number of pups; N, normoxic; H, hyperoxic; NC, normoxic treated with C66; HC, hyperoxic treated with C66; 
NB, normoxic treated with B2BrBC; HB, hyperoxic treated with B2BrBC
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of rat pups exposed to hyperoxia which was preserved by 
CUR analogs. This restoration of CAT activity parallels 
the hyperreactive and attenuated relaxative physiological 
responses of TSM affected by hyperoxic exposure, which 
were effectively reversed by treatment of preparations with 
CUR analogs. CAT causes conversion of H2O2 into water 
and O2, and thus eliminates the paracrine effects of H2O2. 
Decreased CAT activity in conditions of hyperoxia might 
be the direct result of exhausted CAT catalytic activity, due 
to the persistent production of H2O2. Our results show a 
tendency of increased SOD levels in hyperoxic animals, 
however it was not significant. In relation to CUR analogs, 
the activity of SOD increased only in the normoxic group 
treated with C66. Thus, C66 as an enhancer of SOD activ-
ity could be effective in the improvement of hyperoxia-in-
duced impairment. We also assume that both CUR analogs 
have the capacity to attenuate H2O2-mediated mitochon-
drial dysfunction by both, increasing the expression levels 
of antioxidant enzymes (Selvam, Subramanian, Gayathri, 
& Angayarkanni, 1995) and acting as direct ROS scaven-
gers (Kimura, 2014).
Further, based on the obtained results it is more than 
evident that both B2BrBC and C66 possess antiinflamma-
tory properties based on their ability to prevent production 
of proinflammatory cytokines during hyperoxia. There 
are several mechanisms described for CUR derivatives to 
exercise their antiinflammatory activity. Liu et al. (2015), 
reported that derivatives of CUR might alleviate airway 
inflammation in asthma through the Nrf2/HO-1 pathway. 
Other studies suggest that intranasal CUR (2.5 and 5.0 mg/
kg) regulates airway inflammation and airway obstruc-
tion by modulating cytokine levels (IL-4, IL-5, IFN-α, 
and TNF-α) and sPLA2 activity thereby inhibiting PGD2 
release and COX-2 expression (Kumari, Dash, & Singh, 
2017; Masella, Di Benedetto, Varì, Filesi, & Giovannini, 
2005; Subhashini, Chauhan, Dash, Paul, & Singh, 2016). 
The same studies also reveal that suppression of p38 
MAPK, ERK 42/44 and JNK 54/56 activation, with CURs 
protects against asthma progression (Kumari et al., 2017; 
Masella et al., 2005; Subhashini et al., 2016). This supports 
our findings that C66 has more pronounced anti-inflam-
matory effects in comparison to B2BrBC, as measured by 
the proinflammatory cytokine IL-1β in normoxic coun-
terparts. We also believe that hyperoxia by itself induces 
stronger inflammatory reaction that overcomes antiinflam-
matory capacity of C66. In addition, taking that hyperoxia 
induces production of different sets of cytokines from one, 
and cross-reactivity of these with the other endogenously 
produced mediators from the other side, open further spec-
ulation concerning the complexity of the obtained results.
It seems that the reactivity of B2BrBC is dependent on the 
atomic charges of the olefinic carbon atoms (Hadzi-Petrushev 
et al., 2018), and the torsion angles between the aryl ring 
and the adjacent unsaturated groups. The reactivity of this 
system can be tuned by the introduction of various electron 
withdrawing groups in the phenyl rings of which the ortho 
position (X = NO2, CF3 or halides) seemed most promising. 
Based on this, B2BrBC could be classified as a stronger an-
tioxidant and weaker “anti-inflammatory” in comparison to 
C66. Actually, B2BrBC is the α, β-unsaturated monocarbonyl 
CUR analog known as a good Michael acceptor which classi-
fies it as a strong antioxidant (Hadzi-Petrushev et al., 2018). 
This stronger antioxidative capacity is also observed through 
increased relaxation in hyperoxic preparation pretreated with 
B2BrBC.
The model used in this study successfully characterizes 
the protective role of B2BrBC and C66 against hyperoxia-in-
duced hyperreactivity and impairment of relaxation in TSM. 
However, we are aware that the study has some limitations, as 
physiological experiments are performed in isolated prepa-
rations which are disconnected from the systemic circula-
tion and central nervous system, which are important for in 
vivo airway physiology. Pups were exposed to neonatal hy-
peroxia starting at age P5 which represent the transition day 
from saccular to alveolar phase of lung development in rats 
(O’Reilly & Thebaud, 2014). The 5th day of life, as starting 
point for exposure to oxygen might not be critical to induce 
strong structural changes in the airways and interstitial pa-
renchyma of lungs to represent remodeling, but it is critical 
day to induce functional changes in respiratory system, par-
ticularly to trigger airway hyperreactivity that was proven in 
our previous publications (Sopi et al., 2007, 2012). Lungs at 
this age are immature, which is one of the risk factors of BPD 
(Speer, 2006).
This study also lacks the dose–response effect of the newly 
synthesized CUR analogs on contractile responses, because 
we aimed to reverse contractile responses to normal level but 
not to completely diminish, and the single dose we used was 
appropriate to restore the balance between contractile and re-
laxant processes in airway smooth muscle cells.
In conclusion, our results show the effects of B2BrBC 
and C66 to counteract neonatal hyperoxic hyperreactivity on 
TSM and that H2O2 is likely an important hyperoxia-derived 
constrictive mediator in TSM. B2BrBC and C66 preserve the 
activity of CAT, critical for regulation of H2O2 production in 
hyperoxic conditions. The last mechanism may be crucial in 
the amelioration of oxidative dis-balance during hyperoxia. 
Moreover, CUR analogs restored redox balance in the lung 
and reversed impaired relaxation of TSM in hyperoxic condi-
tions. While this is the first study using these newly synthe-
sized CUR analogs in neonatal hyperoxia, future studies are 
planned to investigate additional protective effects of these 
and other newly synthetized CUR analogs in various in vitro 
and in vivo preparations. CUR analogs may be promising 
new therapies for neonatal hyperoxic airway and lung dis-
ease, such as BPD.
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